244 related articles for article (PubMed ID: 35124471)
1. Faeces from malnourished colorectal cancer patients accelerate cancer progression.
Chao X; Lei Z; Hongqin L; Ziwei W; Dechuan L; Weidong D; Lu X; Haitao C; Bo Z; Haixing J; Qinghua Y
Clin Nutr; 2022 Mar; 41(3):632-644. PubMed ID: 35124471
[TBL] [Abstract][Full Text] [Related]
2. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
3. Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer.
Li R; Zhou R; Wang H; Li W; Pan M; Yao X; Zhan W; Yang S; Xu L; Ding Y; Zhao L
Cell Death Differ; 2019 Nov; 26(11):2447-2463. PubMed ID: 30850734
[TBL] [Abstract][Full Text] [Related]
4. Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice.
de Wit S; Geerlings L; Shi C; Dronkers J; Schouten EM; Blancke G; Andries V; Yntema T; Meijers WC; Koonen DPY; Vereecke L; Silljé HHW; Aboumsallem JP; de Boer RA
Cardiovasc Res; 2024 May; 120(6):612-622. PubMed ID: 38400709
[TBL] [Abstract][Full Text] [Related]
5. Metformin Regulates Gut Microbiota Abundance to Suppress M2 Skewing of Macrophages and Colorectal Tumorigenesis in Mice.
Fan L; Zeng X; Xu G
J Microbiol; 2023 Jan; 61(1):109-120. PubMed ID: 36701104
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic test accuracy of nutritional tools used to identify undernutrition in patients with colorectal cancer: a systematic review.
Håkonsen SJ; Pedersen PU; Bath-Hextall F; Kirkpatrick P
JBI Database System Rev Implement Rep; 2015 May; 13(4):141-87. PubMed ID: 26447079
[TBL] [Abstract][Full Text] [Related]
7. Reduced rotavirus vaccine efficacy in protein malnourished human-faecal-microbiota-transplanted gnotobiotic pig model is in part attributed to the gut microbiota.
Srivastava V; Deblais L; Huang HC; Miyazaki A; Kandasamy S; Langel SN; Paim FC; Chepngeno J; Kathayat D; Vlasova AN; Saif LJ; Rajashekara G
Benef Microbes; 2020 Dec; 11(8):733-751. PubMed ID: 33245014
[TBL] [Abstract][Full Text] [Related]
8. Using gut microbiota as a diagnostic tool for colorectal cancer: machine learning techniques reveal promising results.
Lu F; Lei T; Zhou J; Liang H; Cui P; Zuo T; Ye L; Chen H; Huang J
J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37288545
[No Abstract] [Full Text] [Related]
9. Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity.
Ibrahim A; Hugerth LW; Hases L; Saxena A; Seifert M; Thomas Q; Gustafsson JÅ; Engstrand L; Williams C
Int J Cancer; 2019 Jun; 144(12):3086-3098. PubMed ID: 30515752
[TBL] [Abstract][Full Text] [Related]
10. Association of gut microbiome with immune microenvironment in surgically treated colorectal cancer patients.
Han N; Chang HJ; Yeo HY; Kim BC; Kim B; Park SC; Kim J; Park JW; Oh JH
Pathology; 2024 Jun; 56(4):528-539. PubMed ID: 38609782
[TBL] [Abstract][Full Text] [Related]
11. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
[TBL] [Abstract][Full Text] [Related]
12. BRAF
Trivieri N; Pracella R; Cariglia MG; Panebianco C; Parrella P; Visioli A; Giani F; Soriano AA; Barile C; Canistro G; Latiano TP; Dimitri L; Bazzocchi F; Cassano D; Vescovi AL; Pazienza V; Binda E
J Exp Clin Cancer Res; 2020 Dec; 39(1):285. PubMed ID: 33317591
[TBL] [Abstract][Full Text] [Related]
13. Faecal microbial biomarkers in early diagnosis of colorectal cancer.
Olovo CV; Huang X; Zheng X; Xu M
J Cell Mol Med; 2021 Dec; 25(23):10783-10797. PubMed ID: 34750964
[TBL] [Abstract][Full Text] [Related]
14. RNA virus receptor Rig-I monitors gut microbiota and inhibits colitis-associated colorectal cancer.
Zhu H; Xu WY; Hu Z; Zhang H; Shen Y; Lu S; Wei C; Wang ZG
J Exp Clin Cancer Res; 2017 Jan; 36(1):2. PubMed ID: 28057020
[TBL] [Abstract][Full Text] [Related]
15. Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer.
Zhang SL; Cheng LS; Zhang ZY; Sun HT; Li JJ
Pharmacol Res; 2023 Feb; 188():106633. PubMed ID: 36574857
[TBL] [Abstract][Full Text] [Related]
16. Agreement between PG-SGA category and fat-free mass in colorectal cancer patients.
Ræder H; Henriksen C; Bøhn SK; O de Fey Vilbo AR; Henriksen HB; Kværner AS; Rolid K; Paur I; Smeland S; Blomhoff R
Clin Nutr ESPEN; 2018 Oct; 27():24-31. PubMed ID: 30144889
[TBL] [Abstract][Full Text] [Related]
17. YYFZBJS ameliorates colorectal cancer progression in Apc
Sui H; Zhang L; Gu K; Chai N; Ji Q; Zhou L; Wang Y; Ren J; Yang L; Zhang B; Hu J; Li Q
Cell Commun Signal; 2020 Jul; 18(1):113. PubMed ID: 32677955
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota signatures in tissues of the colorectal polyp and normal colorectal mucosa, and faeces.
Zhong X; Wang Y; Xu J; Cao H; Zhang F; Wang X
Front Cell Infect Microbiol; 2022; 12():1054808. PubMed ID: 36704106
[TBL] [Abstract][Full Text] [Related]
19. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis.
Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q
Front Immunol; 2020; 11():588079. PubMed ID: 33072135
[TBL] [Abstract][Full Text] [Related]
20. First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening.
Grobbee EJ; Lam SY; Fuhler GM; Blakaj B; Konstantinov SR; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
United European Gastroenterol J; 2020 Apr; 8(3):293-302. PubMed ID: 32213018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
